Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,618 | Dovepress* | 15,946+ | 1,725 | 17,671 | |
| PubMed Central* | 2,672 | 753 | 3,425 | ||
| Totals | 18,618 | 2,478 | 21,096 | ||
|
*Since 9 July 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar